Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Business Exposures
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
NUTRIBAND AND KINDEVA COMPLETE COMMERCIAL MANUFACTURING PROCESS SCALE-UP FOR AVERSA™ FENTANYL ABUSE DETERRENT FENTANYL PATCH
Via FinancialNewsMedia
Tickers NTRB NTRBW
Exposures Product Safety
Stonegate Capital Partners Initiates Coverage on Cingulate Inc. (CING)
Via Newsfile
Tickers CING
Exposures Product Safety
Thai Research Breakthrough Published in International Scientific Journal A Milestone of Success
Via Newsfile
Topics Death
Exposures Death Product Safety
Q1 Rundown: DexCom (NASDAQ:DXCM) Vs Other Patient Monitoring Stocks
Via StockStory
Topics Artificial Intelligence
Tickers DXCM PODD
Exposures Artificial Intelligence Product Safety
Dyne Therapeutics Stock Drops After ‘Surprise’ Pivot In Primary Endpoint For Muscle Drug Trial
Via Stocktwits
Tickers DYN
Exposures Product Safety
Cero Therapeutics Rockets On FDA Orphan Drug Status For Blood Cancer Drug; Retail Bulls Feel Stock 'Still Has A Few Pumps Left'
Via Stocktwits
Tickers CERO
Exposures Product Safety
FDA Introduces Tumor Board-Style Reviews For Faster Drug Decisions
Via Benzinga
Exposures Product Safety
Waymo Expands Robotaxi Services To More Parts Of San Francisco Bay, Silicon Valley, And Los Angeles
Via Stocktwits
Tickers GOOG GOOGL TSLA
Exposures Product Safety
FDA Aims To Reduce Drug Application Review Time With New Voucher Program
Via Stocktwits
Tickers BAC IHE PJP PPH
Exposures Product Safety
Why Is Dyne Therapeutics Stock Trading Lower On Tuesday?
Via Benzinga
Tickers DYN
Exposures Product Safety
BioMedNewsBreaks – Intelligent Bio Solutions Inc. (NASDAQ: INBS) CEO Highlights Fingerprint Drug Testing on BioMedWire Podcast
Via Investor Brand Network
Topics Cannabis
Tickers INBS
Exposures Cannabis Product Safety
New Tree’s Desugared Juice Revolutionizes Fruit Nutrition: Full Nutritional Value with Zero Sugar and No Guilt
Via Press Release Distribution Service
Topics Economy
Exposures Economy Product Safety
BiomX Stock Could Soar 3000% As This $10M Biotech Cracks The 'Superbug' Code, Wall Street Says
Via News Direct
Tickers PHGE
Exposures Product Safety
Dr. Thomas John Byrne OBGYN Spotlighted for Lifelong Learning and Leadership in Women’s Health
Via Get News
Topics Product Recall
Exposures Legal Product Safety
HeartBeam Inc. (NASDAQ: BEAT) Is ‘One to Watch’
Via Investor Brand Network
Topics Intellectual Property
Tickers BEAT
Exposures Intellectual Property Product Safety
Ocugen (OCGN) Stock Soars On FDA Clearance For Pivotal Stargardt Disease Trial
Via Benzinga
Tickers OCGN
Exposures Product Safety
BioMedNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Forms Investor Relations Partnership With astr Partners
Via Investor Brand Network
Tickers NRXP
Exposures Product Safety
InvestorNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Presents Positive Phase 3 Data on Fibromyalgia Drug at EULAR 2025
Via Investor Brand Network
Tickers TNXP
Exposures Product Safety
BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) VALID-ECG Study Confirms Diagnostic Accuracy of Synthesized 12-Lead ECG
Via Investor Brand Network
Topics Intellectual Property
Tickers BEAT
Exposures Intellectual Property Product Safety
Elite Pharmaceuticals Reports Positive Results from a Pivotal Bioequivalence Study
Via Newsfile
Topics Intellectual Property
Tickers ELTP
Exposures Intellectual Property Product Safety
Sarepta Therapeutics Stock Plummets Over 40% On Second Fatal Case Linked To Its Gene Therapy
Via Benzinga
Topics Death
Tickers RHHBY SRPT
Exposures Death Product Safety
After 19 Explosions And Fire Injuries, Anker Recalls Over 1 Million Power Banks Sold Since 2016 — Is Yours Affected?
Via Benzinga
Topics Product Recall
Exposures Legal Product Safety
UroGen Pharma Stock Scores Bullish Price Target Revisions Up To $47 Following FDA Nod For Zusduri
Via Stocktwits
Tickers GS URGN
Exposures Product Safety
Sarepta Pauses DMD Gene Therapy Trial After Second Death; Retail Traders Brush Off Risk
Via Stocktwits
Tickers SRPT
Exposures Product Safety
Jefferies Names Akero Therapeutics, Scholar Rock As Biotech Companies With Takeover Potential, But Retail Isn’t Pleased
Via Stocktwits
Tickers AKRO GILD LLY PFE
Exposures Product Safety
BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Reported Q1 2025 Results, Advanced Toward Commercialization Following VALID-ECG Study Success
Via Investor Brand Network
Topics Intellectual Property
Tickers BEAT
Exposures Intellectual Property Product Safety
Why UroGen Pharma (URGN) Stock Is Skyrocketing This Week
Via Benzinga
Tickers URGN
Exposures Product Safety
Merck's Keytruda Secures FDA Nod For Head And Neck Cancer As First Immunotherapy For Use Around Surgery
Via Benzinga
Tickers MLTX MRK
Exposures Product Safety
Merck Gets FDA Approval For Keytruda To Treat A Broader Population Of Head And Neck Cancer Patients: Retail Stays Bullish
Via Stocktwits
Topics Death
Tickers AMZN MRK VOO VTI
Exposures Death Product Safety
Limited Impact On Intuitive Surgical From Reprocessed Robotic Instruments: Analyst
Via Benzinga
Tickers ISRG MDT
Exposures Product Safety
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.